CXCL10 and neoplasm: Therefore, CXCL10 can either enhance anti-tumor immunity by recruiting cytotoxic T cells and activating inflammatory responses, or conversely contribute to immunosuppression and resistance to therapy, depending on the tumor context and the involvement of downstream signaling pathways.